Ratings
0
Nobody has rated this yet. Be the first!
Works
6
Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men.
Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).
Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor.
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: The MrOS study
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
